Sian writes about emerging start-up companies and new research from academia. She is especially interested in the pet health space, as well as the introduction of digital technology for both companion animals and livestock. She also has an interest in increasing Animal Pharm's equine coverage, as she owns horses herself.
In addition to covering animal health news and conducting interviews with worldwide companies, Sian also works on the evolving Animal Pharm Product Approvals Index.
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Sian Lazell
Aratana Therapeutics must decide if it will continue the development of a treatment candidate for canine osteoarthritis after analyzing the results of a recent study.
US animal health firm Zomedica Pharmaceuticals has achieved a number of milestones for its pet therapeutics pipeline in 2017.
Dutch firm Le Vet Pharma has received European approval for two generic companion animal products.
French animal feed additives specialist Adisseo has acquired Belgian firm Nutriad for an undisclosed amount.
The European Medicines Agency (EMA) has adopted a positive opinion for a swine vaccine from Zoetis.
A study of Swedish gene therapy firm Panion's epilepsy drug candidate has shown positive initial results.